Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2024-09-27

Clinical Trial Update: A Study to Learn About How Much Emodepside Gets Absorbed in the Blood and How Food Affects Its Absorption When Given as a New Type of Tablet to Healthy Participants [Phase 1]

View source ↗

Summary

Phase 1 study to characterize the pharmacokinetics of emodepside and the effect of food on its absorption in healthy participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Emodepside (emodepside)

Snippet

Sponsor: Bayer | Conditions: Soil-transmitted Helminth Infection, Onchocerciasis (River Blindness) | Phase 1 | Status: COMPLETED